(Reuters) – Pfizer Inc and partner BioNTech SE said on Friday they have submitted new data to the U.S. health regulator showing the stability of their COVID-19 vaccine at temperatures commonly found in pharmaceutical freezers and refrigerators.
(Reporting by Manojna Maddipatla in Bengaluru; Editing by Anil D’Silva)
